In our study, we aimed to examine whether there is a difference in serum MG53 levels between the patient group diagnosed with type 2 DM and the healthy control group without metabolic syndrome and diabetes and to determine the relationship between diabetic complications and glycemic control and MG53 levels in the patient group. Here, TRIM72 is linked to metabolic syndrome.